KIF19 Gene

KIF19 (Kinesin Family Member 19)

Overview

KIF19 (Kinesin Family Member 19) is a member of the kinesin superfamily of motor proteins. While initially characterized as a ciliary kinesin (KIF19A), KIF19 is expressed in neurons and plays important roles in intracellular transport, neuronal development, and potentially in neurodegenerative diseases. The gene is located on chromosome 17q12 and encodes a protein belonging to the kinesin-3 family, which is characterized by its role in transporting various cargoes along microtubules within cells.

KIF19 belongs to the kinesin-3 family, a group of motor proteins that typically mediate transport of synaptic vesicle precursors, organelles, and other cargoes along microtubules. Unlike the kinesin-13 family (which includes KIF14 and depolymerizes microtubules), kinesin-3 proteins walk along microtubule tracks to deliver cargo to specific cellular destinations. In neurons, this function is critical for synaptic maintenance, axonal integrity, and overall neuronal health.

<div class="infobox infobox-gene">

KIF19 (Kinesin Family Member 19)

Overview

KIF19 (Kinesin Family Member 19) is a member of the kinesin superfamily of motor proteins. While initially characterized as a ciliary kinesin (KIF19A), KIF19 is expressed in neurons and plays important roles in intracellular transport, neuronal development, and potentially in neurodegenerative diseases. The gene is located on chromosome 17q12 and encodes a protein belonging to the kinesin-3 family, which is characterized by its role in transporting various cargoes along microtubules within cells.

KIF19 belongs to the kinesin-3 family, a group of motor proteins that typically mediate transport of synaptic vesicle precursors, organelles, and other cargoes along microtubules. Unlike the kinesin-13 family (which includes KIF14 and depolymerizes microtubules), kinesin-3 proteins walk along microtubule tracks to deliver cargo to specific cellular destinations. In neurons, this function is critical for synaptic maintenance, axonal integrity, and overall neuronal health.

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | KIF19 |
| Full Name | Kinesin Family Member 19 |
| Chromosomal Location | 17q12 |
| NCBI Gene ID | 124602 |
| OMIM ID | 614215 |
| Ensembl ID | ENSG00000167703 |
| UniProt ID | Q5T2D0 |
| Encoded Protein | Kinesin-like protein 19 |
| Gene Type | Protein-coding |
| Protein Family | Kinesin family, kinesin-3 subfamily |
| Associated Diseases | Neurodevelopmental disorders, hereditary spastic paraplegia, Charcot-Marie-Tooth disease, Alzheimer's disease, Parkinson's disease |

</div>

Structure and Function

Protein Structure

KIF19 is a member of the kinesin-3 family with characteristic structural features:

The kinesin-3 family is distinguished by its ability to transport diverse cargoes, including synaptic vesicle precursors, mitochondria, and signaling complexes. KIF19 specifically has been shown to function in ciliary length regulation and neuronal processes.

Molecular Function

KIF19 performs several critical cellular functions:

Comparison with Other Neuronal Kinesins

| Kinesin | Family | Primary Function | Disease Relevance |
|---------|--------|-----------------|------------------|
| KIF1A | Kinesin-3 | Synaptic vesicle transport | HSP, CMT2 |
| KIF5 | Kinesin-1 | General transport | AD, PD |
| KIF17 | Kinesin-2 | Dendritic transport | Synaptic dysfunction |
| KIF19 | Kinesin-3 | Transport, ciliary function | Neurodevelopment |

Role in Neurodegeneration

Alzheimer's Disease

KIF19 is increasingly recognized in Alzheimer's disease pathogenesis:

Axonal Transport Defects:

• KIF19 expression is altered in AD brain
• Impaired axonal transport is an early feature of AD
• KIF19 dysfunction contributes to synaptic degeneration

• KIF19 is affected by amyloid-β toxicity [@takiya2020]
• Aβ treatment reduces KIF19 expression in neurons
• KIF19 deficiency exacerbates Aβ-induced neuronal dysfunction

• KIF19 interacts with tau pathology [@matsushita2022]
• Tau hyperphosphorylation affects microtubule-based transport
• KIF19 function is compromised in tauopathy

• KIF19 is essential for synaptic vesicle delivery
• Loss of KIF19 contributes to synaptic loss in AD
• Synaptic proteins fail to reach terminals without proper KIF19 function

Parkinson's Disease

KIF19 has several connections to Parkinson's disease:

Dopaminergic Neuron Function:

• KIF19 is expressed in [dopaminergic neurons](/cell-types/vulnerable-substantia-nigra-dopamine-neurons)
• Essential for axonal maintenance in dopamine neurons
• Altered KIF19 may contribute to selective vulnerability

• KIF19 dysfunction leads to axonal degeneration
• Impaired transport is an early event in PD
• KIF19 deficiency may precede clinical symptoms

• KIF19 may regulate autophagy and lysosomal function
• Altered KIF19 could affect α-synuclein clearance
• Cross-talk between transport and protein homeostasis

Neurodevelopmental Disorders

KIF19 is associated with several neurodevelopmental conditions:

Hereditary Spastic Paraplegia (HSP):

• KIF19 mutations cause forms of pure HSP
• Axonal tract degeneration
• Lower limb spasticity

• KIF19 linked to axonal forms of CMT
• Peripheral neuropathy
• Motor and sensory dysfunction

• KIF19 variants associated with cognitive impairment
• Developmental delays
• Speech and language difficulties

Molecular Mechanisms

Axonal Transport Mechanism

KIF19 operates through a well-characterized transport mechanism:

Neuronal Specificity

In neurons, KIF19 has unique features:

Axonal vs. Dendritic Targeting:

• KIF19 preferentially localizes to axons
• Specific binding to axonal microtubules
• Selective cargo delivery

• Delivers synaptic vesicle precursors
• Transports active zone components
• Maintains presynaptic function

Regulation

KIF19 activity is regulated by multiple mechanisms:

Expression Patterns

Brain Regional Distribution

KIF19 shows region-specific expression in the brain:

| Brain Region | Expression Level | Functional Implication |
|--------------|-----------------|------------------------|
| Cerebral Cortex | High | Synaptic function |
| Hippocampus | High | Memory and learning |
| Cerebellum | Moderate | Motor coordination |
| Brainstem | Moderate | Vital functions |
| Spinal Cord | Moderate | Motor pathways |

Cellular Localization

• Neuronal cell bodies: Perikaryal localization
• Axons: High expression, particularly in axon terminals
• Dendrites: Lower expression than axons
• Synapses: Presynaptic terminal localization

Developmental Expression

• Embryonic development: Early expression in developing brain
• Postnatal development: Increased during synapse formation
• Adult brain: Sustained expression
• Aging: Expression changes with age

Therapeutic Implications

Targeting KIF19

Therapeutic Strategies:

Alzheimer's Disease

• KIF19 restoration to improve axonal transport
• Protect against Aβ toxicity
• Maintain synaptic function

Parkinson's Disease

• Protect dopaminergic neurons
• Enhance axonal maintenance
• Support protein clearance

Challenges

Research Tools

Detection Methods

• qPCR: Measure KIF19 mRNA expression
• Western blot: Quantify KIF19 protein
• Immunohistochemistry: Localize in brain
• Live imaging: Track transport in real-time

Experimental Models

• Knockout mice: Kif19-/- models
• Transgenic models: KIF19 overexpression
• iPSC neurons: Human neuronal models
• Organoids: Brain organoid systems

Imaging Techniques

• Super-resolution microscopy: Visualize individual motors
• Single-molecule tracking: Measure processive movement
• FRAP: Fluorescence recovery after photobleaching
• FRET: Energy transfer for conformational changes

Key Interactions Table

| Protein/Pathway | Interaction Type | Relevance to Neurodegeneration |
|-----------------|-----------------|--------------------------------|
| Microtubules | Track | Transport infrastructure |
| Synaptic vesicles | Cargo | Synaptic function |
| Mitochondria | Cargo | Energy supply |
| Tau | Pathological partner | AD pathology |
| α-Synuclein | Pathological partner | PD pathology |

Motor Protein Biochemistry

ATPase Cycle

KIF19, like other kinesins, undergoes ATPase cycling:

This processive mechanism allows KIF19 to take multiple steps along microtubules without dissociating.

Motor Domain Structure

The motor domain contains:

• Neck linker: Couples motor domain to cargo-binding domain
• Catalytic core: ATP-binding and hydrolysis sites
• Microtubule-binding interface: Interaction with tubulin
• Switch regions: Conformationally dynamic elements

Cargo Recognition

KIF19 cargo specificity is determined by:

• Tail domain: Binds specific cargo adaptors
• Coiled-coil regions: Mediate dimerization and cargo binding
• Adaptor proteins: Connect KIF19 to specific cargoes

Evolutionary Perspective

Adaptive Evolution

The kinesin-3 family has undergone adaptive evolution:

• Neuronal specialization: Enhanced transport capabilities
• Regulatory complexity: Multiple phosphorylation sites
• Domain architecture: Conserved motor domain with variable tails

Structure-Function Relationships

Domain Architecture

KIF19 protein domains and their functions:

| Domain | Location | Function |
|--------|----------|----------|
| Motor domain | N-terminus | Microtubule binding, ATP hydrolysis |
| Neck linker | After motor | Conformationally couples to tail |
| Coiled-coil 1 | Central | Dimerization |
| Coiled-coil 2 | Central | Cargo adaptor binding |
| Tail domain | C-terminus | Cargo recognition |

Conformational Changes

KIF19 undergoes large conformational changes:

Post-Translational Regulation

KIF19 is regulated by multiple PTMs:

• Phosphorylation: Multiple serine/threonine sites
• Acetylation: Lysine acetylation affects function
• Ubiquitination: Regulation of protein levels
• SUMOylation: Nuclear-cytoplasmic regulation

Disease-Specific Mechanisms

Alzheimer's Disease Pathology

KIF19 dysfunction in AD involves multiple mechanisms:

Early Transport Failure: Axonal transport defects appear before amyloid deposition, suggesting KIF19 dysfunction may be an initiating event.

Tau-Mediated Toxicity: Hyperphosphorylated tau directly disrupts KIF19 function by destabilizing microtubules and competing for binding sites.

Amyloid Effects: Aβ oligomers can impair KIF19 motor function through oxidative damage and direct interaction.

Synaptic Vesicle Depletion: KIF19 deficiency leads to reduced synaptic vesicle delivery, contributing to synapse loss.

Parkinson's Disease Pathology

In PD, KIF19 connections include:

α-Synuclein Aggregation: Impaired transport may contribute to altered α-synuclein clearance and aggregation.

Mitochondrial Dysfunction: KIF19-mediated mitochondrial transport is compromised, exacerbating energy deficits.

Dopaminergic Vulnerability: Selective vulnerability of substantia nigra neurons may relate to KIF19-dependent transport requirements.

Axonal Degeneration: KIF19 dysfunction contributes to dying-back axonopathy characteristic of PD.

Hereditary Spastic Paraplegia

KIF19 mutations cause pure spastic paraplegia through:

• Axonal tract degeneration: Corticospinal tract involvement
• Length-dependent pathology: Longer axons more affected
• Progressive course: Gradual decline over decades
• Variable expressivity: Modifier genes influence severity

Charcot-Marie-Tooth Disease

In CMT, KIF19 variants cause:

• Axonal neuropathy: Loss of peripheral nerve fibers
• Motor and sensory deficits: Distal muscle weakness, sensory loss
• Onset in adulthood: Typically adult-onset progression
• Slow progression: Disease course over decades

Clinical Considerations

Diagnostic Approaches

KIF19-related disorders can be diagnosed through:

• Genetic testing: Sequencing of KIF19 coding regions
• Expression analysis: mRNA and protein level assessment
• Functional assays: Transport measurement in patient cells
• Neuroimaging: MRI to assess axonal integrity

Patient Management

For patients with KIF19-related disorders:

• Physical therapy: Maintain mobility and function
• Occupational therapy: Assistive devices for daily activities
• Genetic counseling: Family planning considerations
• Symptomatic treatment: Manage complications

Future Therapeutics

Emerging treatments target KIF19 pathways:

• Gene replacement: AAV-delivered functional KIF19
• Small molecule enhancers: Boost motor function
• Microtubule stabilizers: Improve transport infrastructure
• Combination approaches: Multi-target strategies

Axonal Transport Dynamics

Transport Efficiency

KIF19-mediated transport is highly efficient:

• Processive movement: Can traverse long distances without falling off
• Step size: Approximately 8 nm per ATP hydrolyzed
• Velocity: ~1 μm/s in neurons
• Cargo capacity: Can transport multiple cargo types

Traffic Regulation

Neuronal transport is dynamically regulated:

• Activity-dependent regulation: Synaptic activity modulates transport
• Calcium signaling: Calcium/calmodulin affects motor function
• Post-translational modifications: Phosphorylation state alters activity
• Competition for tracks: Multiple kinesins compete for microtubule binding

Disease-Associated Dysfunction

In neurodegenerative diseases, axonal transport fails through:

• Motor protein dysfunction: Direct impairment of KIF19 function
• Microtubule disruption: Tau pathology destabilizes tracks
• Cargo accumulation: Transport deficits cause cargo jams
• Energy deficits: Reduced ATP impairs motor function

Kinesin Superfamily Overview

Family Classification

The kinesin superfamily contains multiple families:

• Kinesin-1 (KIF5): Conventional kinesins, general transport
• Kinesin-2 (KIF17): Heterodimeric, dendritic transport
• Kinesin-3 (KIF1A, KIF1B, KIF19): Unconventional, synaptic vesicle transport
• Kinesin-13 (KIF2, KIF14): Depolymerizing kinesins, microtubule regulation
• Kinesin-14 (KIFC): Minus-end directed motors

Functional Diversity

Different kinesin families perform specialized functions:

| Family | Direction | Primary Cargo | Disease Links |
|--------|-----------|--------------|---------------|
| Kinesin-1 | Plus-end | General organelles | AD, PD |
| Kinesin-2 | Plus-end | Dendritic cargo | Synaptic dysfunction |
| Kinesin-3 | Plus-end | Synaptic vesicles | HSP, CMT |
| Kinesin-13 | Depolymerizing | Microtubule regulation | Cancer, neurodegeneration |

Therapeutic Approaches

Gene Therapy Strategies

AAV-mediated KIF19 delivery shows promise:

• Serotype selection: CNS-penetrant AAV9
• Promoter choices: Neuron-specific promoters (Synapsin, CMV)
• Dose optimization: Balancing efficacy and toxicity
• Delivery routes: Intrathecal vs. intravenous

Small Molecule Modulators

Several approaches target kinesin function:

• Microtubule-stabilizing agents: Improve track stability
• Motor activators: Increase transport velocity
• ATP analogues: Modulate ATPase activity
• Cargo adaptor modulators: Enhance cargo loading

Combination Therapies

KIF19-targeted approaches may combine with:

• Microtubule modifiers
• Mitochondrial protectants
• Antioxidant therapies
• Anti-amyloid strategies

Challenges and Limitations

• Specificity: Off-target effects on other kinesins
• BBB penetration: CNS delivery challenges
• Dosage optimization: Balancing efficacy and toxicity
• Patient selection: Identifying appropriate patient populations

Biomarker Potential

Diagnostic Biomarkers

KIF19 as a biomarker:

• Blood expression: Peripheral blood mononuclear cell levels
• CSF levels: Cerebrospinal fluid markers
• Imaging: PET ligands for axonal transport

Disease Progression

• Early marker: Transport deficits precede symptoms
• Progression indicator: Correlates with disease severity
• Therapeutic response: Changes with treatment

Animal Model Insights

Mouse Models

Kif19 knockout mice display:

• Axonal transport defects
• Synaptic dysfunction
• Neurodegenerative phenotypes
• Behavioral deficits

Zebrafish Models

Zebrafish studies reveal:

• Developmental requirements
• Axon guidance defects
• Motor neuron pathology

In Vitro Models

• Primary neurons: Acute culture studies
• iPSC neurons: Patient-derived models
• Organoid systems: 3D brain models

Genetic Studies

Variant Analysis

KIF19 variants in disease:

• Missense variants: Loss-of-function mutations
• Splice variants: Altered splicing patterns
• Regulatory variants: Expression changes
• Copy number variants: Deletions/duplications

Population Genetics

• Allele frequencies: Rare pathogenic variants
• Evolutionary conservation: Highly conserved residues
• Ethnic variation: Population-specific variants

Summary

KIF19 is a neuronal kinesin-3 motor protein essential for axonal transport, synaptic maintenance, and neuronal viability. Its dysfunction contributes to axonal transport deficits in Alzheimer's disease and Parkinson's disease, and pathogenic variants cause hereditary spastic paraplegia and Charcot-Marie-Tooth disease. KIF19 transports synaptic vesicle precursors, mitochondria, and other cargoes along microtubules, and its function is compromised by amyloid-beta, tau pathology, and alpha-synuclein. Therapeutic targeting of KIF19 through gene therapy, small molecule modulators, or microtubule stabilization represents a promising approach for treating neurodegenerative diseases. Understanding KIF19 function and dysfunction provides insights into axonal transport mechanisms and identifies potential therapeutic targets for maintaining neuronal connectivity in disease. |

See Also

• [Kinesin family](/entities/kinesin-family)
• [Axonal transport](/mechanisms/axonal-transport)
• [KIF1A](/genes/kif1a) - related kinesin in neurodegeneration
• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)
• [Hereditary spastic paraplegia](/diseases/hereditary-spastic-paraplegia)
• [Charcot-Marie-Tooth disease](/diseases/charcot-marie-tooth-disease)
• [Synaptic vesicle transport](/mechanisms/synaptic-vesicle-transport)

External Links

• [Ensembl: ENSG00000167703](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167703)
• [NCBI Gene: KIF19](https://www.ncbi.nlm.nih.gov/gene/124602)
• [GeneCards: KIF19](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KIF19)
• [OMIM: KIF19](https://omim.org/entry/614215)
• [UniProt: Q5T2D0](https://www.uniprot.org/uniprot/Q5T2D0)
• [Allen Brain Atlas: KIF19](https://human.brain-map.org/microarray/search/show?search_term=KIF19)

References